VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,051,359 | -9.0% | 295,504 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $4,453,281 | +196.8% | 277,463 | +43.5% | 0.00% | – |
| Q1 2023 | $1,500,668 | -38.2% | 193,385 | +54.1% | 0.00% | -100.0% |
| Q4 2022 | $2,428,057 | -0.8% | 125,481 | +9.2% | 0.00% | 0.0% |
| Q3 2022 | $2,448,000 | +59.9% | 114,870 | +2.1% | 0.00% | – |
| Q2 2022 | $1,531,000 | -40.4% | 112,470 | +2.8% | 0.00% | – |
| Q1 2022 | $2,570,000 | +23.6% | 109,407 | +40.5% | 0.00% | – |
| Q4 2021 | $2,080,000 | +102.1% | 77,853 | +31.3% | 0.00% | – |
| Q3 2021 | $1,029,000 | – | 59,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |